- Advertise
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Georgia Cancer Center at Augusta University | Strategic Alliance Partners
The Georgia Cancer Center at Augusta University brings together a team of basic science researchers, clinicians, radiation oncologists, nurse navigators and patient support staff to create a community fostering innovation and care focused on improving the lives of our patients. This team approach is focused on patients across the state of Georgia and neighboring states providing access to more first-in-the-nation clinical trials, world-renowned experts and a multidisciplinary approach that keeps the patient at the center of care. Research at the Georgia Cancer Center’s M. Bert Storey Research Building focuses on the most promising pathways for the prevention and treatment of cancer. Several of our researchers are involved with investigator-initiated clinical trials, transitioning their research into the clinic.
Latest from Georgia Cancer Center at Augusta University
Paceline Ride Donates $126,000 to Advance Research Projects at the Georgia Cancer Center
October 08, 2021
Article
The Paceline Ride, LLC team delivered a check for $126,000 to the Georgia Cancer Center at Augusta University.
Augusta University Community Encouraged to Register for Paceline Event in October
October 01, 2021
Article
The Augusta University community is encouraged to participate in this year’s Paceline bicycle ride on October 16.
Dr. Cortes on the Challenges of Using Ruxolitinib in MPNs
April 24, 2020
Video
Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the challenges of using ruxolitinib (Jakafi) in patients with myeloproliferative neoplasms (MPNs).
Managing Treatment Toxicity in CML and MPNs
April 14, 2020
Article
Jorge E. Cortes, MD, discusses managing treatment toxicities to optimize therapeutic outcomes in patients with CML and MPNs.
Cortes Underscores Rationale for BCMA-Directed Therapy in Multiple Myeloma
March 19, 2020
Article
Jorge E. Cortes, MD, discusses the evolution of multiple myeloma treatment, the role of BCMA-directed therapies, and remaining questions that need to be addressed in this space
Dr. Cortes on the Advantage of BCMA-Targeted Therapy in Multiple Myeloma
March 19, 2020
Video
Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the advantage of BCMA-targeted therapy in multiple myeloma.
Dr. Ghamande on the AIM2CERV Trial in Cervical Cancer
January 13, 2018
Video
Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.
Dr. Ghamande Discusses GOG/NRG 0265 Study in Cervical Cancer
November 09, 2017
Video
Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the GOG/NRG-0265 study in cervical cancer.
Therapy Combinations May Become the Treatment of Choice in Ovarian Cancer
July 12, 2017
Article
The future of treatment for ovarian cancer may lie in immunotherapy combinations with PARP inhibitors or checkpoint inhibitors.